Cell Growth & Differentiation, Vol 7, Issue 3 311-318, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells

M Mandal and R Kumar
Department of Medicine, Pennsylvania State University College of Medicine, Hershey 17033, USA.

Sodium butyrate (butyrate) is a potent growth inhibitor and differentiating agent for many cell types, including breast cancer cells. Programmed cell death, or apoptosis, is a physiological mechanism of cell death that is dependent on both preexisting proteins and de novo protein synthesis. In the studies presented here, we investigated the role of apoptosis in the growth regulation of human MCF-7 breast cancer cells by sodium butyrate. We report that butyrate treatment of breast cancer MCF-7 cells causes a nonreversible growth inhibition by inducing apoptosis in a time- and dose-dependent manner. Treatment of MCF-7 cells for as little as 12 h with butyrate caused a 5.6-fold induction in apoptotic cell death, which continued to increase up to 27-fold by 48 h treatment. The butyrate-induced apoptosis in MCF-7 cells was closely linked with the down-regulation of expression of Bcl-2 mRNA and Bcl-2 protein, a gene product known to be involved in the regulation of apoptosis in mammalian cells. The observed relationship between the down-regulation of Bcl-2 and induction of apoptosis was not causal because stable overexpression of Bcl-2 resulted in protection of MCF-7 cells from the cytotoxic morphological changes and growth-inhibitory effects of butyrate (15% growth inhibition compared to 60% growth inhibition in the parental cells). In addition, Bcl-2-overexpressing MCF-7 cells exhibited a significant suppression in butyrate-induced stimulation of apoptosis (5-fold increase in apoptosis compared to 27-fold in parental MCF-7 cells). These findings demonstrate that the levels of Bcl-2 expression regulate the butyrate-induced apoptosis in breast cancer cells and that butyrate may potentially be useful in sensitizing the breast cancer cells to chemotherapy-induced apoptosis.

This article has been cited by other articles:

				F. Docquier, D. Farrar, V. D'Arcy, I. Chernukhin, A. F. Robinson, D. Loukinov, S. Vatolin, S. Pack, A. Mackay, R. A. Harris, et al. Heightened Expression of CTCF in Breast Cancer Cells Is Associated with Resistance to Apoptosis Cancer Res., June 15, 2005; 65(12): 5112 - 5122. [Abstract] [Full Text] [PDF]

				X. D. Zhang, S. K. Gillespie, J. M. Borrow, and P. Hersey The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells Mol. Cancer Ther., April 1, 2004; 3(4): 425 - 435. [Abstract] [Full Text] [PDF]

				J. L. Merchant, L. Bai, and M. Okada ZBP-89 Mediates Butyrate Regulation of Gene Expression J. Nutr., July 1, 2003; 133(7): 2456S - 2460. [Abstract] [Full Text] [PDF]

				R. R. Rosato, J. A. Almenara, L. Cartee, V. Betts, S. P. Chellappan, and S. Grant The Cyclin-dependent Kinase Inhibitor Flavopiridol Disrupts Sodium Butyrate-induced p21WAF1/CIP1 Expression and Maturation while Reciprocally Potentiating Apoptosis in Human Leukemia Cells Mol. Cancer Ther., February 1, 2002; 1(4): 253 - 266. [Abstract] [Full Text] [PDF]

				K. Mortensen, J. Skouv, D. M. Hougaard, and L.-I. Larsson Endogenous Endothelial Cell Nitric-oxide Synthase Modulates Apoptosis in Cultured Breast Cancer Cells and Is Transcriptionally Regulated by p53 J. Biol. Chem., December 31, 1999; 274(53): 37679 - 37684. [Abstract] [Full Text] [PDF]

				L. Dong, W. Wang, F. Wang, M. Stoner, J. C. Reed, M. Harigai, I. Samudio, M. P. Kladde, C. Vyhlidal, and S. Safe Mechanisms of Transcriptional Activation of bcl-2Gene Expression by 17{beta}-Estradiol in Breast Cancer Cells J. Biol. Chem., November 5, 1999; 274(45): 32099 - 32107. [Abstract] [Full Text] [PDF]

				S. Ruller, C. Stahl, G. Kohler, B. Eickhoff, J. Breder, M. Schlaak, and J. van der Bosch Sensitization of Tumor Cells to Ribotoxic Stress-induced Apoptotic Cell Death: A New Therapeutic Strategy Clin. Cancer Res., October 1, 1999; 5(10): 2714 - 2725. [Abstract] [Full Text] [PDF]

				H. Huang, C. P. Reed, J.-S. Zhang, V. Shridhar, L. Wang, and D. I. Smith Carboxypeptidase A3 (CPA3): A Novel Gene Highly Induced by Histone Deacetylase Inhibitors during Differentiation of Prostate Epithelial Cancer Cells Cancer Res., June 1, 1999; 59(12): 2981 - 2988. [Abstract] [Full Text] [PDF]

				B. G. Heerdt, M. A. Houston, G. M. Anthony, and L. H. Augenlicht Initiation of Growth Arrest and Apoptosis of MCF-7 Mammary Carcinoma Cells by Tributyrin, a Triglyceride Analogue of the Short-Chain Fatty Acid Butyrate,Is Associated with Mitochondrial Activity Cancer Res., April 1, 1999; 59(7): 1584 - 1591. [Abstract] [Full Text] [PDF]

				P. W. Parodi Cows' Milk Fat Components as Potential Anticarcinogenic Agents J. Nutr., June 1, 1997; 127(6): 1055 - 1060. [Abstract] [Full Text]

				M. Mandal and R. Kumar Bcl-2 Modulates Telomerase Activity J. Biol. Chem., May 30, 1997; 272(22): 14183 - 14187. [Abstract] [Full Text] [PDF]

				M. Mandal, S. B. Maggirwar, N. Sharma, S. H. Kaufmann, S.-C. Sun, and R. Kumar Bcl-2 Prevents CD95 (Fas/APO-1)-induced Degradation of Lamin B and Poly(ADP-ribose) Polymerase and Restores the NF-{kappa}B Signaling Pathway J. Biol. Chem., November 29, 1996; 271(48): 30354 - 30359. [Abstract] [Full Text] [PDF]